Luis Benlloch

700 total citations
10 papers, 162 citations indexed

About

Luis Benlloch is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Luis Benlloch has authored 10 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 2 papers in Oncology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Luis Benlloch's work include Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Multiple Myeloma Research and Treatments (2 papers). Luis Benlloch is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Multiple Myeloma Research and Treatments (2 papers). Luis Benlloch collaborates with scholars based in Spain, Chile and Switzerland. Luis Benlloch's co-authors include Guillermo Sanz, Miguel Á. Sanz, Javier de la Rubia, David Valcárcel, Elisa Luño, R. de Paz, Mari Luz Amigo, Pablo Martínez‐Camblor, Joaquín Sánchez‐García and Carmen Pedro and has published in prestigious journals such as Blood, Leukemia and Transfusion.

In The Last Decade

Luis Benlloch

9 papers receiving 161 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis Benlloch Spain 5 149 48 37 31 24 10 162
Eisaku Iwanaga Japan 8 122 0.8× 47 1.0× 42 1.1× 70 2.3× 20 0.8× 19 179
Sabina Sufliarska Slovakia 6 95 0.6× 41 0.9× 57 1.5× 17 0.5× 32 1.3× 15 154
Katsuhiro Shono Japan 7 71 0.5× 31 0.6× 35 0.9× 28 0.9× 26 1.1× 20 134
Evandro M. Fagundes Brazil 8 121 0.8× 30 0.6× 48 1.3× 52 1.7× 32 1.3× 19 154
Atelda Romano Italy 8 168 1.1× 33 0.7× 51 1.4× 74 2.4× 34 1.4× 16 200
Jean-Michel Cayuela France 3 107 0.7× 31 0.6× 38 1.0× 39 1.3× 15 0.6× 6 122
K. Douglas United Kingdom 5 177 1.2× 30 0.6× 24 0.6× 15 0.5× 44 1.8× 7 194
Fryderyk Lorenz Sweden 10 193 1.3× 79 1.6× 27 0.7× 66 2.1× 15 0.6× 18 239
Germana Beltrami Italy 6 96 0.6× 29 0.6× 32 0.9× 37 1.2× 45 1.9× 12 130
Mohamed Houhou France 9 181 1.2× 29 0.6× 87 2.4× 27 0.9× 39 1.6× 14 197

Countries citing papers authored by Luis Benlloch

Since Specialization
Citations

This map shows the geographic impact of Luis Benlloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Benlloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Benlloch more than expected).

Fields of papers citing papers by Luis Benlloch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Benlloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Benlloch. The network helps show where Luis Benlloch may publish in the future.

Co-authorship network of co-authors of Luis Benlloch

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Benlloch. A scholar is included among the top collaborators of Luis Benlloch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Benlloch. Luis Benlloch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Díez‐Campelo, María, Luis Benlloch, Emma Chen Sasse, et al.. (2021). Treatment Patterns and Overall Survival in Patients with Intermediate-Risk MDS: A Retrospective Analysis in the Spanish MDS Registry. Blood. 138(Supplement 1). 2605–2605. 2 indexed citations
2.
Alonso, Sara, José Bruno Montoro Ronsano, Luis Benlloch, et al.. (2017). Long Tracking Analysis About Management of Azacitidine in Patients with Myelodysplastic Syndrome. Leukemia Research. 55. S66–S66.
3.
Bernal, Teresa, Pablo Martínez‐Camblor, Joaquín Sánchez‐García, et al.. (2015). Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry. Leukemia. 29(9). 1875–1881. 67 indexed citations
4.
Sánchez‐Barba, Mercedes, Rodrigo Martino, Guillermo Sanz, et al.. (2014). Results of allogeneic stem cell transplantation in the Spanish MDS registry: Prognostic factors for low risk patients. Leukemia Research. 38(10). 1199–1206. 6 indexed citations
5.
García‐Casado, Zaida, Ana Valencia, Eva Barragán, et al.. (2006). SHP-1 (PTPN6) Gene Supression by FLT3/ITD Defines an Aggressive Subgroup of Myeloid Malignancies.. Blood. 108(11). 1907–1907. 1 indexed citations
6.
Sanz, Guillermo, Ignacio Lorenzo, Federico Moscardó, et al.. (2004). Outcome and Prognostic Factors after Unrelated Donor Umbilical Cord Blood Transplantation in Adult Patients with Hematologic Malignancies Transplanted in Early Disease Stages.. Blood. 104(11). 2149–2149. 4 indexed citations
7.
Sanz, Guillermo, Federico Moscardó, Carmen Jiménez, et al.. (2004). Unrelated-donor cord blood transplantation in patients with chronic myeloid leukemia. Biology of Blood and Marrow Transplantation. 10(10). 734–734. 1 indexed citations
8.
Rubia, Javier de la, Guillermo Martı́n, José Cervera, et al.. (2002). FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies. Leukemia Research. 26(8). 725–730. 30 indexed citations
9.
Rubia, Javier de la, Miguel Ángel Díaz, Amparo Verdeguer, et al.. (2001). Donor age‐related differences in PBPC mobilization with rHuG–CSF. Transfusion. 41(2). 201–205. 41 indexed citations
10.
Cervera, Javier Lizardi, Guillermo Sanz, D. Irriguible, et al.. (1997). 27 Does WBC count really define two different subtypes of chronic myelomonocytic leukemia (CMML)? Analysis of a series of 119 patients. Leukemia Research. 21(1). S7–S7. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eisaku Iwanaga Breakdown of academic impact, for papers by Sabina Sufliarska Breakdown of academic impact, for papers by Katsuhiro Shono Breakdown of academic impact, for papers by Evandro M. Fagundes Breakdown of academic impact, for papers by Atelda Romano Breakdown of academic impact, for papers by Jean-Michel Cayuela Breakdown of academic impact, for papers by K. Douglas Breakdown of academic impact, for papers by Fryderyk Lorenz Breakdown of academic impact, for papers by Germana Beltrami Breakdown of academic impact, for papers by Mohamed Houhou
Rankless by CCL
2026